BDS
CRL icon

Banco de Sabadell’s Charles River Laboratories CRL Stock Holding History

Banco de Sabadell’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,140
Closed -$880K – 363
2019
Q1 		$880K Buy
+6,140
New +$807K 0.12% 161

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Banco de Sabadell's CRL Position: Q2 2019 in Review

Banco de Sabadell sold out of Charles River Laboratories (CRL) in Q2 2019, closing a stake of 6,140 shares — an estimated $880K sold.

Banco de Sabadell first reported a position in CRL in Q1 2019 and held it in 1 quarter. The position peaked at $880K in Q1 2019. 405 funds tracked by Wall St. Rank hold CRL as of Q2 2019.

  • Banco de Sabadell reported no remaining Charles River Laboratories position as of Q2 2019 after selling out during the quarter.
  • Banco de Sabadell sold 6,140 Charles River Laboratories shares in Q2 2019, an estimated $880K.
  • Banco de Sabadell first reported a position in Charles River Laboratories in Q1 2019 and held it in 1 quarter.
  • Banco de Sabadell's Charles River Laboratories position peaked at $880K in Q1 2019.
  • 405 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2019.

Based on Banco de Sabadell's 13F filing for Q2 2019, filed 13 Aug 2019.